ConductScience.org, home

Paper41360073

Manufacture of Clostridioides difficile Spores for Experimental Infection of Human Volunteers.

Hensen ADO and 12 others. J Infect Dis, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Manufacture of Clostridioides difficile Spores for Experimental Infection of Human Volunteers. Papers, record 41360073. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41360073

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Manufacture of Clostridioides difficile Spores for Experimental Infection of Human Volunteers.
PubMed
Journal
J Infect Dis
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hensen ADOAnnefleur D Ohttps://orcid.org/0009-0000-0987-8301
2Harmanus CCélinehttps://orcid.org/0000-0002-5328-3273
3Voorvelt CChristinehttps://orcid.org/0009-0008-4922-583X
4Geelen ARAnoecim R
5El Hamdioui MMaryam
6Kuijper EJEd Jhttps://orcid.org/0000-0001-5726-2405
7Pattacini LLaurahttps://orcid.org/0000-0003-1702-4781
8Schipper PPimhttps://orcid.org/0009-0008-2402-0897
9van Amerongen-Westra IMInge Mhttps://orcid.org/0009-0009-3271-495X
10Meij PPaulinehttps://orcid.org/0000-0003-3370-9932
11van der Stoep MYECM Y Eileen Chttps://orcid.org/0000-0001-7643-8592
12Roestenberg MMetahttps://orcid.org/0000-0002-5052-2830
13Smits WKWiep Klaashttps://orcid.org/0000-0002-7409-2847

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Clostridioides difficileMajor topic
Spores, BacterialMajor topic
Clostridium InfectionsMajor topic
Humans
Quality Control
Capsules
Healthy Volunteers

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Innovative Medicines InitiativePubMed
European UnionPubMed
EFPIAPubMed

Source PubMed

Download CSV of grants

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126493844Emerging bacterial pathogens: the past and beyond.Clin Microbiol Infect2016https://conductscience.org/library/papers/26493844PubMed
228378789Novel micelle PCR-based method for accurate, sensitive and quantitative microbiota profiling.Sci Rep2017https://conductscience.org/library/papers/28378789PubMed
334911367Comparison of Whole-Genome Sequence-Based Methods and PCR Ribotyping for Subtyping of Clostridioides difficile.J Clin Microbiol2022https://conductscience.org/library/papers/34911367PubMed
434808546Clostridioides difficile spore germination: initiation to DPA release.Curr Opin Microbiol2022https://conductscience.org/library/papers/34808546PubMed
539214188How to develop a controlled human infection model for Clostridioides difficile.Clin Microbiol Infect2025https://conductscience.org/library/papers/39214188PubMed
636287379
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Drugs2022https://conductscience.org/library/papers/36287379PubMed
727001804Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor.Clin Infect Dis2016https://conductscience.org/library/papers/27001804PubMed
835045228SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.N Engl J Med2022https://conductscience.org/library/papers/35045228PubMed
939884503Antimicrobial susceptibility testing of Clostridioides difficile: a dual-site study of three different media and three therapeutic antimicrobials.Clin Microbiol Infect2025https://conductscience.org/library/papers/39884503PubMed
1036509372Clostridioides difficile infection with isolates of cryptic clade C-II: a genomic analysis of polymerase chain reaction ribotype 151.Clin Microbiol Infect2023https://conductscience.org/library/papers/36509372PubMed
1123323867Duodenal infusion of donor feces for recurrent Clostridium difficile.N Engl J Med2013https://conductscience.org/library/papers/23323867PubMed
1225942722Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.JAMA2015https://conductscience.org/library/papers/25942722PubMed
1338175470Diagnostic Guidance for C. difficile Infections.Adv Exp Med Biol2024https://conductscience.org/library/papers/38175470PubMed
1434678515European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.Clin Microbiol Infect2021https://conductscience.org/library/papers/34678515PubMed
1535505774Human infection studies: Key considerations for challenge agent development and production.Wellcome Open Res2022https://conductscience.org/library/papers/35505774PubMed
1639885121Metagenomic global survey and in-depth genomic analyses of Ruminococcus gnavus reveal differences across host lifestyle and health status.Nat Commun2025https://conductscience.org/library/papers/39885121PubMed
1723103666Clostridium difficile: a European perspective.J Infect2013https://conductscience.org/library/papers/23103666PubMed
1825679978Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile.PLoS One2015https://conductscience.org/library/papers/25679978PubMed
1940288746Clostridioides difficile is a bacterial priority pathogen.Anaerobe2025https://conductscience.org/library/papers/40288746PubMed
2029891332Experimental infection of human volunteers.Lancet Infect Dis2018https://conductscience.org/library/papers/29891332PubMed

See all 23 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42286003Experimental human colonisation with non-toxigenic Clostridioides difficile: a placebo-controlled randomised clinical trial.Nat Commun2026https://conductscience.org/library/papers/42286003

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41360073

GET https://conductscience.org/api/papers/v1/41360073/references?page=2